Dan T. Vogl, MD¹, Shebli Atrash, MD^2*, Sarah A. Holstein, MD, PhD³, Omar Nadeem, MD⁴, Don M. Benson Jr., MD⁵, Kaveri Suryanarayan, MD^6*, Yuyin Liu^6*, Sabrina Collins^6*, Xavier Parot, MD^6* and Jonathan L. Kaufman, MD⁷

¹Abramson Cancer Center, Trustees of The University of Pennsylvania, Philadelphia, PA
²Levine Cancer Institute, Charlotte, NC
³University of Nebraska Medical Center, Omaha, NE
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Ohio State University Comprehensive Cancer Center, Columbus, OH
⁶Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
⁷Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Luciano J. Megala Costa, MD, PhD¹, Shaji K Kumar, MD², Shebli Atrash, MD^3*, Michaela Liedtke, MD⁴, Gurbakhash Kaur, MD⁵, Benjamin A. Derman, MD⁶, P. Leif Bergsagel, MD⁷, Sham Mailankody, MBBS ⁸, Philip L. McCarthy, MD⁹, Josiana Limones^10*, Yanping Chen, PhD^10*, Sharmila Das^10*, Jerill Thorpe, BS^10*, Jonathan Cacciatore^10*, Garnet Navarro^10*, Ashley K Koegel^10*, Michael R. Burgess, MD, PhD^10*, Kristen Hege, MD¹⁰ and Shambavi Richard, MD¹¹

¹University of Alabama at Birmingham Hospital, Vestavia, AL
²Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
³Atrium Health Levine Cancer Institute, Charlotte, NC
⁴Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁵Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁶Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
⁸Memorial Sloan Kettering Cancer Center, New York, NY
⁹Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁰Bristol Myers Squibb, Princeton, NJ
¹¹Mount Sinai Health System, New York, NY

Suzanne Trudel¹, Nizar J. Bahlis, MD², Andrew Spencer³, Rayan Kaedbey, MD⁴, Paula Rodriguez Otero^5*, Simon J Harrison, MD⁶, Chihunt Wong^7*, Grant R. Goodman, MD⁷, Rin Nakamura^7*, Voleak Choeurng^7*, James Cooper^7* and Maria-Victoria Mateos, MD⁸

¹Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada
²Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
³Alfred Health-Monash University, Melbourne, VIC, Australia
⁴Jewish General Hospital, McGill University, Montreal, QC, Canada
⁵Clínica Universidad de Navarra, Pamplona, Spain
⁶Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, Melbourne University, and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁷Genentech, Inc., South San Francisco, CA
⁸Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain

Paul G. Richardson, MD¹, Suzanne Trudel², Hang Quach³, Rakesh Popat^4*, Sagar Lonial, MD⁵, Robert Z. Orlowski, MD, PhD⁶, Kihyun Kim, MD⁷, María-Victoria Mateos, MD, PhD⁸, Charlotte Pawlyn, PhD^9,10, Karthik Ramasamy¹¹, Joaquín Martinez-Lopez, MD, PhD^12*, Alessia Spirli^13*, Ignacio Casas-Avilés, MD^14*, Jing Gong, PhD^15*, Michael Amatangelo, PhD^15*, Jessica Katz, MD PhD^15*, Paulo Maciag, MD PhD^15*, Teresa Peluso^13* and Nizar J. Bahlis, MD¹⁶

¹Dana-Farber Cancer Institute, Boston, MA
²Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
³St. Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia
⁴NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵Winship Cancer Institute, Emory University, Atlanta, GA
⁶Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan Univ. Sch. of Med. Samsung Medical Center, Seoul, Korea, Republic of (South)
⁸University Hospital of Salamanca/IBSAL, Salamanca, Spain
⁹The Royal Marsden NHS Foundation, London, United Kingdom
¹⁰The Institute of Cancer Research, London, United Kingdom
¹¹Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
¹²Department of Hematology, Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical Research Unit, CIBERONC, Madrid, Spain
¹³Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹⁴Hospital San Pedro de Alcántara, Cáceres, Spain
¹⁵Bristol Myers Squibb, Princeton, NJ
¹⁶University of Calgary, Calgary, AB, Canada

Salomon Manier, MD, PhD¹, Jill Corre^2*, Cyrille Hulin^3*, Kamel Laribi^4*, Carla Araujo^5*, Gian-Matteo Pica, MD^6*, Cyrille Touzeau^7*, Pascal Godmer, MD^8*, Bohrane Slama^9*, Lionel Karlin^10*, Frederique Orsini-Piocelle^11*, Mamoun Dib, MD^12*, Margaret Macro, MD^13*, Laurence Sanhes, MD^14*, Aurore Perrot, MD, PhD^15*, Jean Yves Mary, PhD^16*, Jerome Lambert, MD, PhD^17*, Herve Avet-Loiseau, MD, PhD^18*, Philippe Moreau, MD^19*, Xavier Leleu, MD, PhD²⁰ and Thierry Facon^21*

¹Lille University Hospital, Lille, France
²Unité de Génomique du Myélome, IUCT- Oncopole, Toulouse, France
³Department of Hematology, University Hospital Bordeaux, Bordeaux, France
⁴Le Mans University Hospital, Le Mans, FRA
⁵Centre Hospitalier de la Cote Basque, Bayonne, France, Bayonne, FRA
⁶Department of Hematology, Centre Hospitalier Métropole Savoie Chambéry, Chambéry, France
⁷University Hospital Hôtel Dieu, Nantes Cedex 1, FRA
⁸Clinical Hematology, Centre Hospitalier Bretagne Atlantique, Vannes, France
⁹CH Avignon, Avignon, FRA
¹⁰Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Bénite, France
¹¹Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, FRA
¹²Hématologie - CHU - Hôpital du Bocage, Angers, France
¹³Haematology Department, Caen University Hospital, Caen, France
¹⁴Department of Hematology, CH de Perpignan, Perpignan, France
¹⁵Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
¹⁶INSERM, Paris, France
¹⁷Biostatistics Department, University of Paris, AP-HP, Saint Louis Hospital, Paris, FRA
¹⁸Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France
¹⁹Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
²⁰Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France
²¹Department of Hematology, Lille University Hospital, Lille, France

Charlotte Pawlyn, PhD^1,2, Tom Menzies^3*, Faith E Davies, MD⁴, Ruth M. de Tute^5*, Rowena Henderson^3*, Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath^3,6*, Matthew W Jenner^7*, John R Jones, MD^8,9,10*, Martin F. Kaiser, MD, FRCP, FRCPath^1,2, Mark T Drayson, MD^11*, Roger G Owen^5*, David Cairns, PhD^3*, Gareth J. Morgan, MD⁴ and Graham Jackson, MBBS, FRCP, FRCPath, MA, DM¹²

¹The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
²The Institute of Cancer Research, London, United Kingdom
³Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴Perlmutter Cancer Center, NYU Langone Health, New York, NY
⁵HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁶Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
⁷Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
⁸Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom
⁹King's College Hospital NHS Foundation Trust, London, United Kingdom
¹⁰Eastbourne District General Hospital, Eastbourne, United Kingdom
¹¹Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
¹²Department of Haematology, University of Newcastle, Newcastle upon Tyne, United Kingdom